Enteric infection acts as an adjuvant for the response to a model food antigen1

Journal of Immunology

Volumn 165, Issue 11, 2000, Pages 6174-6182

  Hai Ning Shi, ^a   Hao Yuan Liu, ^a   Nagler Anderson, C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; FOOD ANTIGEN;

ADOPTIVE TRANSFER; ALLERGIC REACTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; IMMUNE RESPONSE; INTESTINE INFECTION; MESENTERY LYMPH NODE; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTAKE; RECEPTOR UPREGULATION; T LYMPHOCYTE ACTIVATION;

EID: 0034544445     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.11.6174     Document Type: Article

References (36)

1. Heat-killed Listeria monocytogenes as an adjuvant converts established murine Th2-dominated immune responses into Th1-dominated responses
2. A natural immunological adjuvant enhances T cell clonal expansion through a CD28-dependent, interleukin (IL)-2-independent mechanism
3. Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: Adjuvant action is associated with enhanced regulatory cytokine production and expression of the co-stimulatory molecules B7-1, B7-2 and CD28
4. The mucosal adjuvanticity of cholera toxin involves enhancement of costimulatory activity by selective upregulation of B7.2 expression
5. Direct effects on antigen-presenting cells and T lymphocytes explain the adjuvanticity of a nontoxic cholera toxin mutant
6. CpG DNA is a potent enhancer of systemic and mucosal immune response against hepatitis B surface antigen with intranasal administration to mice
7. Use of adoptive transfer of T cell-antigen-receptor-transgenic T cells for the study of T cell activation in vivo
8. A helminth-induced mucosal Th2 response alters nonresponsiveness to oral administration of a soluble antigen
9. 10 thymocytes in vivo
10. Antigen-specific T cell activation and proliferation during oral tolerance induction
11. Determination of lymphocyte division by flow cytometry
12. Dynamics and requirements of T cell clonal expansion in vivo at the single cell level: Effector function is linked to proliferative capacity
13. Following the fate of individual T cells throughout activation and clonal expansion: Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response
14. Orally induced peripheral nonresponsiveness is maintained in the absence of functional Th1 or Th2 cells
15. Effects of blocking BT-1 and B7-2 interactions during a type 2 in vivo immune response
16. Visualization of peptide specific T cell immunity and peripheral tolerance induction in vivo
17. + T cells specific for an antigen expressed in Escherichia coli
18. + T cells persist in vivo following induction of peripheral tolerance
19. The MHC-restricted antigen receptor on T cells. 1. Isolation of a monoclonal antibody
20. + T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4
21. Direct measurement of anergy of antigen-specific T cells following oral tolerance induction
22. Inductive events in oral tolerance in the TCR transgenic adoptive transfer model
23. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement
24. Functional roles of Fas and Bcl-2 regulated apoptosis of T lymphocytes
25. Antigen-experienced CD4 T cells display a reduced capacity for clonal expansion in vivo that is imposed by factors present in the immune host
26. Visualizing the T-cell response elicited by oral administration of soluble protein antigen
27. The induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen
28. + T cells
29. Oral tolerance: Physiological basis and clinical applications
30. + T cell tolerance induction versus priming is independent of the rate and number of cell divisions
31. Modulating dendritic cells to optimize mucosal immunization protocols
32. + T cells
33. IL-1 is an effective adjuvant for mucosal and systemic immune responses when coadministered with protein immunogens
34. Tumor necrosis factor α is a critical component of interleukin 13-mediated protective T helper cell type 2 responses during helminth infection
35. Nematode infection enhances survival of activated T cells by modulating accessory cell function
36. Tolerance and immunity in the intestinal immune system